Evidence map›Paper›PMID 32119094›Full record

ArticleJAMA network open2020

Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms.

Thomas Schaffter, Diana S M Buist, Christoph I Lee, Yaroslav Nikulin, Dezso Ribli, Yuanfang Guan, William Lotter, Zequn Jie, Hao Du, Sijia Wang and 64 more

Erratum issuedAbstract read
In one paragraph

Article in JAMA network open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 176 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
176citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

176 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

116 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

74 authors.

Thomas SchaffterComputational Oncology, Sage Bionetworks, Seattle, Washington.
Diana S M BuistKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Christoph I LeeUniversity of Washington School of Medicine, Seattle.
Yaroslav NikulinTherapixel, Paris, France.
Dezso RibliDepartment of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
Yuanfang GuanDepartment of Computational Medicine and Bioinformatics, Michigan Medicine, University of Michigan, Ann Arbor.
William LotterDeepHealth Inc, Cambridge, Massachusetts.
Zequn JieTencent AI Lab, Shenzhen, China.
Hao DuNational University of Singapore, Singapore.
Sijia WangIntegrated Health Information Systems Pte Ltd, Singapore.
Jiashi FengDepartment of Electrical and Computer Engineering, National University of Singapore, Singapore.
Mengling FengNational University Health System, Singapore.
Hyo-Eun KimLunit Inc, Seoul, Korea.
Francisco AlbiolInstituto de Física Corpuscular (IFIC), CSIC-Universitat de València, Valencia, Spain.
Alberto AlbiolUniversitat Politecnica de Valencia, Valencia, Valenciana, Spain.
Stephen MorrellCentre for Medical Image Computing, University College London, Bloomsbury, London, United Kingdom.
Zbigniew WojnaTensorflight Inc, Mountain View, California.
Mehmet Eren AhsenUniversity of Illinois at Urbana-Champaign, Urbana.
Umar AsifIBM Research Australia, Melbourne, Australia.
Antonio Jimeno YepesIBM Research Australia, Melbourne, Australia.
Shivanthan YohanandanIBM Research Australia, Melbourne, Australia.
Simona Rabinovici-CohenIBM Research Haifa, Haifa University Campus, Mount Carmel, Haifa, Israel.
Darvin YiStanford University, Stanford, California.
Bruce HoffComputational Oncology, Sage Bionetworks, Seattle, Washington.
Thomas YuComputational Oncology, Sage Bionetworks, Seattle, Washington.
Elias Chaibub NetoComputational Oncology, Sage Bionetworks, Seattle, Washington.
Daniel L RubinDepartment of Biomedical Data Science, Radiology, and Medicine (Biomedical Informatics), Stanford University, Stanford, California.
Peter LindholmDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Laurie R MargoliesDepartment of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Russell Bailey McBrideDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Joseph H RothsteinDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Weiva SiehDepartment of Population Health Science and Policy, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Rami Ben-AriIBM Research Haifa, Haifa University Campus, Mount Carmel, Haifa, Israel.
Stefan HarrerIBM Research Australia, Melbourne, Australia.
Andrew TristerFred Hutchinson Cancer Research Center, Seattle, Washington.
Stephen FriendComputational Oncology, Sage Bionetworks, Seattle, Washington.
Thea NormanBill and Melinda Gates Foundation, Seattle, Washington.
Berkman SahinerCenter for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
Fredrik StrandDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Justin GuinneyComputational Oncology, Sage Bionetworks, Seattle, Washington.
Gustavo StolovitzkyIBM Research, Translational Systems Biology and Nanobiotechnology, Thomas J. Watson Research Center, Yorktown Heights, New York.
and the DM DREAM Consortium
Lester MackeyMicrosoft New England Research and Development Center, Cambridge, Massachusetts.
Joyce CahoonNorth Carolina State University, Raleigh.
Li ShenIcahn School of Medicine at Mount Sinai, New York, New York.
Jae Ho SohnDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco.
Hari TrivediEmory University, Atlanta, Georgia.
Yiqiu ShenNew York University, New York.
Ljubomir ButurovicClinical Persona, East Palo Alto, California.
Jose Costa PereiraInstitute for Systems and Computer Engineering, Technology and Science, Porto, Portugal.
Jaime S CardosoInstitute for Systems and Computer Engineering, Technology and Science, Porto, Portugal.
Eduardo CastroInstitute for Systems and Computer Engineering, Technology and Science, Porto, Portugal.
Karl Trygve KallebergKolibriFX, Oslo, Norway.
Obioma PelkaDepartment of Computer Science, University of Applied Sciences and Arts, Dortmund, Germany.
Imane NedjarBiomedical Engineering Laboratory Tlemcen University, Tlemcen, Algeria.
Krzysztof J GerasDepartment of Radiology, NYU School of Medicine, New York, New York.
Felix NensaDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
Ethan GoanQueensland University of Technology, Brisbane, Australia.
Sven KoitkaDepartment of Computer Science, University of Applied Sciences and Arts, Dortmund, Germany.
Luis CaballeroInstituto de Física Corpuscular (IFIC), CSIC-Universitat de València, Valencia, Spain.
David D CoxMIT-IBM Watson AI Lab, IBM Research, Cambridge, Massachusetts.
Pavitra KrishnaswamyInstitute for Infocomm Research, A*STAR, Singapore.
Gaurav PandeyDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Christoph M FriedrichDepartment of Computer Science, University of Applied Sciences and Arts, Dortmund, Germany.
Dimitri PerrinQueensland University of Technology, Brisbane, Australia.
Clinton FookesQueensland University of Technology, Brisbane, Australia.
Bibo ShiCarl E. Ravin Advanced Imaging Laboratories, Department of Radiology, Duke University School of Medicine, Durham, North Carolina.
Gerard Cardoso NegrieSatalia, London, United Kingdom.
Michael KawczynskiBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco.
Kyunghyun ChoNew York University, New York.
Can Son KhooUniversity College London, London, United Kingdom.
Joseph Y LoDepartment of Radiology, Duke University School of Medicine, Durham, North Carolina.
A Gregory SorensenDeepHealth Inc, Cambridge, Massachusetts.
Hwejin JungKorea University, Seoul, Korea.

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Diana L Miglioretti · 2011 to 2026
$52.9M
POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
TR&D 4: Revealing Microstructure: Biophysical modeling and validation for discovery and clinical careP41EB017183 · NIBIB · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Hersh Chandarana · 2014 to 2026
$19.3M
Artificial Intelligence for Improved Breast Cancer Screening Accuracy: External Validation, Refinement, and Clinical TranslationR37CA240403 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CHRISTOPH I LEE · 2020 to 2026
$3.8M
Machine Learning for Drug Response PredictionR35GM133346 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Yuanfang Guan · 2019 to 2026
$3.2M
NCI NIH HHS P01 CA154292NCI NIH HHS R37 CA240403NIBIB NIH HHS P41 EB017183NIGMS NIH HHS R35 GM133346
6 · The paper itself

Abstract

Importance: Mammography screening currently relies on subjective human interpretation. Artificial intelligence (AI) advances could be used to increase mammography screening accuracy by reducing missed cancers and false positives. Objective: To evaluate whether AI can overcome human mammography interpretation limitations with a rigorous, unbiased evaluation of machine learning algorithms. Design, Setting, and Participants: In this diagnostic accuracy study conducted between September 2016 and November 2017, an international, crowdsourced challenge was hosted to foster AI algorithm development focused on interpreting screening mammography. More than 1100 participants comprising 126 teams from 44 countries participated. Analysis began November 18, 2016. Main Outcomes and Measurements: Algorithms used images alone (challenge 1) or combined images, previous examinations (if available), and clinical and demographic risk factor data (challenge 2) and output a score that translated to cancer yes/no within 12 months. Algorithm accuracy for breast cancer detection was evaluated using area under the curve and algorithm specificity compared with radiologists' specificity with radiologists' sensitivity set at 85.9% (United States) and 83.9% (Sweden). An ensemble method aggregating top-performing AI algorithms and radiologists' recall assessment was developed and evaluated. Results: Overall, 144 231 screening mammograms from 85 580 US women (952 cancer positive ≤12 months from screening) were used for algorithm training and validation. A second independent validation cohort included 166 578 examinations from 68 008 Swedish women (780 cancer positive). The top-performing algorithm achieved an area under the curve of 0.858 (United States) and 0.903 (Sweden) and 66.2% (United States) and 81.2% (Sweden) specificity at the radiologists' sensitivity, lower than community-practice radiologists' specificity of 90.5% (United States) and 98.5% (Sweden). Combining top-performing algorithms and US radiologist assessments resulted in a higher area under the curve of 0.942 and achieved a significantly improved specificity (92.0%) at the same sensitivity. Conclusions and Relevance: While no single AI algorithm outperformed radiologists, an ensemble of AI algorithms combined with radiologist assessment in a single-reader screening environment improved overall accuracy. This study underscores the potential of using machine learning methods for enhancing mammography screening interpretation.

Indexed as

Deep LearningRadiologistsAdultAgedAlgorithmsArtificial IntelligenceBreast NeoplasmsEarly Detection of CancerFemaleHumansImage Interpretation, Computer-AssistedMammographyMiddle AgedRadiologySensitivity and SpecificitySweden

Identifiers

PMID32119094
PMCPMC7052735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.